Diabetic peripheral neuropathic pain Clinical Trials

11 recruitingLast updated: May 11, 2026

There are 11 actively recruiting diabetic peripheral neuropathic pain clinical trials across 10 countries. Studies span Phase 2, Phase 1, Phase 3, Not Applicable, Phase 4. Top locations include DeLand, Florida, United States, Beachwood, Ohio, United States, Birmingham, Alabama, United States. Updated daily from ClinicalTrials.gov.


Diabetic peripheral neuropathic pain Trials at a Glance

11 actively recruiting trials for diabetic peripheral neuropathic pain are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in DeLand, Beachwood, and Birmingham. Lead sponsors running diabetic peripheral neuropathic pain studies include Vertex Pharmaceuticals Incorporated, Florida A&M University, and Eli Lilly and Company.

Browse diabetic peripheral neuropathic pain trials by phase

Treatments under study

About Diabetic peripheral neuropathic pain Clinical Trials

Looking for clinical trials for Diabetic peripheral neuropathic pain? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetic peripheral neuropathic pain trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetic peripheral neuropathic pain clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 1Phase 2

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

Diabetic NeuropathiesDiabetic Peripheral Neuropathic Pain (DPN)
Florida A&M University20 enrolled1 locationNCT07298408
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated1,100 enrolled76 locationsNCT06628908
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated734 enrolled65 locationsNCT07231419
Recruiting
Phase 2

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic pain
Vertex Pharmaceuticals Incorporated300 enrolled47 locationsNCT06619860
Recruiting
Phase 2

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

painful peripheral neuropathyChemotherapy-induced Peripheral Neuropathy (CIPN)Diabetic Peripheral Neuropathic Pain (DPN)+1 more
University of Rochester190 enrolled7 locationsNCT06614322
Recruiting
Phase 1

A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain

Diabetic peripheral neuropathic pain
Shandong Suncadia Medicine Co., Ltd.168 enrolled2 locationsNCT07377721
Recruiting
Phase 2

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

Diabetic peripheral neuropathic pain
Eli Lilly and Company150 enrolled37 locationsNCT07285018
Recruiting
Phase 4

Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain (DPNP)
Bangladesh Medical University78 enrolled1 locationNCT07451431
Recruiting
Phase 1

MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP

Diabetic peripheral neuropathic pain
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.24 enrolled1 locationNCT06361108
Recruiting
Phase 2

Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin

Diabetic peripheral neuropathic pain
Haisco Pharmaceutical Group Co., Ltd.90 enrolled1 locationNCT06490484
Recruiting
Not Applicable

Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathic painElectroacupunctureAcupuncture+3 more
Instituto Mexicano del Seguro Social200 enrolled1 locationNCT05521737